Hospital
ST Bernard Community Hospital Corporation
ST Bernard Community Hospital Corporation was paid $1.77M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 17% of everything it billed.
33Billing provider infoST BERNARD COMMUNITY HOSPITAL CORPORATION
WYNNE, AR 72396
WYNNE, AR 72396
33aNPI1962410183assigned 08/03/2006
33bProvider typeCritical Access Hospital
28Total paid$1.77M
24GClaims113,329
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#7 of 34
Median peer was paid$773K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,080 | $201K | |
| 2019 | 15,058 | $241K | |
| 2020 | 13,664 | $222K | |
| 2021 | 12,584 | $235K | |
| 2022 | 18,965 | $296K | |
| 2023 | 22,871 | $335K | |
| 2024incomplete | 16,107 | $237K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 17% | 8,358 | 1,717 | $294K |
| 70450 | Computed tomography, head or brain; without contrast material | 12% | 1,892 | 1,677 | $217K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.2% | 1,448 | 1,318 | $128K |
| 80053 | Comprehensive metabolic panel | 7.1% | 9,252 | 7,678 | $125K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.9% | 4,519 | 3,640 | $103K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.5% | 4,626 | 2,465 | $79K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.1% | 9,433 | 7,839 | $73K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 1,237 | 1,102 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 4,138 | 3,498 | $48K |
| 71045 | Radiologic examination, chest; single view | 2.1% | 4,335 | 3,778 | $38K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 1,282 | 1,085 | $35K |
| 83880 | 1.7% | 1,490 | 1,274 | $30K |
74 more codes
| 84484 | 1.7% | 3,365 | $30K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 312 | $30K |
| 83874 | 1.7% | 2,515 | $30K | |
| 87400 | 1.7% | 4,051 | $29K | |
| 82553 | 1.6% | 2,511 | $29K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 3,041 | $26K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 10,016 | $25K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,123 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 675 | $25K |
| 99284 | Emergency room visit (serious) | 1.2% | 2,280 | $22K |
| 81001 | 1.1% | 5,535 | $20K | |
| 82550 | 1.1% | 2,574 | $19K | |
| 94760 | 1.0% | 1,554 | $18K | |
| 87081 | <1% | 1,816 | $16K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 723 | $14K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 69 | $13K |
| 80305 | <1% | 1,099 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,891 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 120 | $11K |
| 97162 | <1% | 95 | $10K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 232 | $9K |
| 87428 | <1% | 165 | $8K | |
| 87040 | <1% | 975 | $8K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 582 | $8K |
| 83605 | <1% | 780 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 475 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 960 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 720 | $6K |
| 85027 | <1% | 1,355 | $5K | |
| 83690 | <1% | 668 | $5K | |
| 81025 | <1% | 636 | $5K | |
| 87077 | <1% | 712 | $4K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 27 | $4K |
| 80061 | Lipid panel | <1% | 577 | $3K |
| 86756 | <1% | 195 | $3K | |
| 83735 | <1% | 570 | $3K | |
| 87186 | <1% | 699 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 64 | $3K |
| 73562 | <1% | 72 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 41 | $3K |
| 85610 | <1% | 951 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $2K |
| 82150 | <1% | 250 | $2K | |
| 82962 | <1% | 461 | $2K | |
| 71020 | <1% | 130 | $2K | |
| 86140 | <1% | 317 | $2K | |
| 71010 | <1% | 252 | $1K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 17 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 385 | $1K |
| 97001 | <1% | 32 | $1K | |
| 97161 | <1% | 13 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 176 | $1K |
| 85379 | <1% | 99 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $1K |
| 73030 | <1% | 40 | $958.76 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $780.31 |
| 73630 | <1% | 29 | $739.20 | |
| 85730 | <1% | 141 | $684.31 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 28 | $425.80 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 46 | $400.53 |
| 82803 | <1% | 17 | $291.41 | |
| 80320 | <1% | 16 | $211.53 | |
| 73610 | <1% | 13 | $209.70 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 19 | $207.64 |
| 90715 | <1% | 30 | $203.97 | |
| 82565 | <1% | 26 | $176.55 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 17 | $158.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $93.52 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 47 | $57.56 |
| 36416 | <1% | 63 | $53.73 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 93 | $39.15 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 577 | $7.73 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 54 | $0.00 |
| 90670 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATTES, BRYAN (ASSOCIATE ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| ST Bernard Community Hospital Corporation | Wynne, AR | $399K |
| ST Bernard Community Hospital Corporation | Wynne, AR | $286K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.